Evidence shows benefit of RSV vaccines as Trump officials push restrictions

AI Summary
Recent evidence confirms that RSV vaccines significantly reduce hospitalizations in infants, yet US officials are moving to restrict access to the shots. Led by Robert F. Kennedy Jr., the Trump administration now recommends the vaccine only for high-risk babies, despite data showing its effectiveness in preventing severe illness in all infants. Experts worry this restriction will lead to a surge in RSV hospitalizations, as most affected babies have no underlying conditions. Unlike the UK, Australia, and Denmark, which recommend the vaccine during pregnancy and have universal healthcare, the US has lower rates of maternal vaccination and fragmented care, making universal infant vaccination more critical. Studies in JAMA support the observation that RSV shots have led to a major decrease in hospitalizations.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis. The political bias score ranges from -1 (far left) to +1 (far right).
Topic Connections
Explore how the topics in this article connect to other news stories